Affiliation:
1. Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802
2. Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205
Abstract
Using epitope- and structure-based multiepitope fusion antigen vaccinology platform, we constructed a polyvalent protein immunogen that presents antigenic domains (epitopes) of
Vibrio cholerae
toxin-coregulated pilus A, cholera toxin (CT), sialidase, hemolysin A, flagellins (B, C, and D), and peptides mimicking lipopolysaccharide O-antigen on a flagellin B backbone. Mice and rabbits immunized intramuscularly with this polyvalent protein immunogen developed antibodies to all of the virulence factors targeted by the immunogen except lipopolysaccharide. Mouse and rabbit antibodies exhibited functional activities against CT enterotoxicity, CT binding to GM
1
ganglioside, bacterial motility, and in vitro adherence of
V. cholerae
O1, O139, and non-O1/non-O139 serogroup strains. When challenged orogastrically with
V. cholerae
O1 El Tor N16961 or a non-O1/non-O139 strain, rabbits IM immunized with the immunogen showed a 2-log (99%) reduction in
V. cholerae
colonization of small intestines. Moreover, infant rabbits born to the mother immunized with the protein immunogen acquired antibodies passively and were protected from bacterial intestinal colonization (>2-log reduction), severe diarrhea (100%), and mild diarrhea (88%) after infection with
V. cholerae
O1 El Tor (N16961), O1 classical (O395), O139 (Bengal), or a non-O1/non-O139 strain. This study demonstrated that this polyvalent cholera protein is broadly immunogenic and cross-protective, and an adult rabbit colonization model and an infant rabbit passive protection model fill a gap in preclinical efficacy assessment in cholera vaccine development.
Funder
UofI, Department of Pathobiology, University of Illinois at Urbana-Champaign
HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Publisher
Proceedings of the National Academy of Sciences
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1–CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic
Escherichia coli
(ETEC);Microbiology Spectrum;2024-04-02
2. Polyvalent passive vaccine candidates from egg yolk antibodies (IgY) of important outer membrane proteins (PF1380 and ExbB) of Pseudomonas fluorescens in fish;Fish & Shellfish Immunology;2023-12
3. Recent advances in enterotoxin vaccine adjuvants;Current Opinion in Immunology;2023-12
4. Protein-based vaccine candidate MecVax broadly protects against enterotoxigenic
Escherichia coli
intestinal colonization in a rabbit model;Infection and Immunity;2023-11-16
5. A Polyvalent Adhesin–Toxoid Multiepitope-Fusion-Antigen-Induced Functional Antibodies against Five Enterotoxigenic Escherichia coli Adhesins (CS7, CS12, CS14, CS17, and CS21) but Not Enterotoxins (LT and STa);Microorganisms;2023-10-01